Back to results
US 2020/0399592 A1Published application
Suspension culture of human embryonic stem cells
AssigneeAsterias Biotherapeutics, Inc.
InventorsRamkumar Mandalam, Yan Li, Isabelle Nadeau-Demers
Life of this patent
Estimating the term…
Abstract
This disclosure provides an improved system for culturing human embryonic stem cells. The cells are cultured in suspension so as to maximize the production capacity of the culture environment. The new culture system of this invention allows for bulk proliferation of hES cells in a more cost-effective manner, which facilitates commercial production of important products for use in human therapy.
Claims10
-18. (canceled)
A system or kit for culturing human pluripotent stem (hPS) cells in suspension, comprising a nutrient medium that contains at least 40 ng/mL fibroblast growth factor (FGF).
Dependencies are inferred from the claim text.